EXTENSIVE LINE OF LIQUID STABLE & READY-TO-USE CLINICAL REFERENCE MATERIALS AVAILABLE FROM VERICHEM LABORATORIES

VERICHEM LABORATORIES has announced the availability of an extensive line of ready-to-use, liquid stable Clinical Reference Materials intended intended for the calibration and calibration verification of clinical testing systems.

Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month

MedAI: Explore Therapeutic Antibody Discovery and Development for Disease Treatment

Organocatalysts Available at Alfa Chemistry Catalysts: High Quality and Cost-Effective

Data Analysis at MedAI: PrediXcan Based Analysis and BSLMM Prediction

Gut Microbiota Bioinformatics Services Now Available by the GutFlora Omics Platform

Gut microbiota bioinformatics services help understand how the gut microbiota colonizes, varies and interacts with the host, and even how to associate with diseases can be of great value in the treatment of these diseases, such as inflammatory bowel disease (IBD), diabetes, mental disorders, and cancers.

European Medicines Agency Selects Panalgo for Real-World Data Analytics

Panalgo's IHD software to be used by the EMA to rapidly answer questions around drug safety and efficacy and better understand real-world medication use.

Pronalyse Division Announced Vaccines Analysis Service to Ensure Vaccine Safety

Pronalyse is dedicated to providing professional analysis services in biopharmaceutical development. Recently, the product manager has announced the vaccines analysis service to ensure the safety, efficacy, purity and potency of vaccine products.

BioPure and Teknomek collaborate to deliver optimum workplace efficiency and hygiene confidence Status message

Teknomek worked in collaboration with BioPure, taking account of employee welfare and clean room risk management, to create the ideal specification to support operational process and minimise risk.

Shimmer’s Verisense® Wearable Sensing Platform Selected for Boston University Brain Health Studies

These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.

Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing

ZEISS Announces Collaborative Research Partnership with Max Planck Florida Institute for Neuroscience

The press release announces ZEISS has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI).

‘UK government can deliver Brexit benefit with world’s best medicines security’ say FarmaTrust

Company forewarns the UK is risking fake COVID-19 vaccines and other medicines without a new system

Samsung Biologics Shares ‘Vision’ for Next Decade at the 39th Annual JP Morgan Healthcare Conference

Jumpcode Genomics Secures $21M in Series B Funding

The RSA Group welcomes Eleanor Davies as Managing Partner

The RSA Group, a leading Life Sciences Executive Search firm, is delighted to announce the appointment of a new senior team member. Eleanor Davies joins the company as Managing Partner.

Global healthtech company Raremark appoints Nicki Grundy as its Chief Financial Officer

Raremark, the global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.

Antibiotic Research UK announces the appointment of Mr. Simon Dukes as Chair Designate of the Board of Trustees

Antibiotic Research UK is delighted to announce the appointment of Mr. Simon Dukes as Chair Designate of its Board of Trustees.

Optibrium Enhances Compound Design Strategies in Major Upgrade to StarDrop Software

• New features include reaction-based library enumeration for novel molecule generation and optimisation • AI-integrated with seamless interface to Optibrium’s Artificial Intelligence platform, Cerella, to extract greater value from drug discovery data